- Home
- HSCS vs ACCS Comparison
HSCS vs ACCS Comparison
Compare HSCS & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSCS | ACCS |
|---|---|---|
| Founded | 2007 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Publishing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 13.6M |
| IPO Year | 2022 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HSCS | ACCS |
|---|---|---|
| Price | $2.40 | $3.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.50 |
| AVG Volume (30 Days) | ★ 80.3K | 8.4K |
| Earning Date | 12-14-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.84 | ★ 139.36 |
| EPS | N/A | ★ N/A |
| Revenue | $4,319.00 | ★ $22,619,000.00 |
| Revenue This Year | $295.93 | N/A |
| Revenue Next Year | $18,321.05 | $5.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.63 | $3.21 |
| 52 Week High | $5.25 | $11.34 |
Technical Indicators
Market Signals| Indicator | HSCS | ACCS |
|---|---|---|
| Relative Strength Index (RSI) | 35.12 | 24.56 |
| Support Level | $1.84 | N/A |
| Resistance Level | $2.76 | $5.11 |
| Average True Range (ATR) | 0.34 | 0.28 |
| MACD | -0.07 | -0.03 |
| Stochastic Oscillator | 19.75 | 16.72 |
Price Performance
Historical ComparisonAbout HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
About ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.